Phase III Trial of Febuxostat in Korea Gout Patients

NCT00821392 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

181

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout

Interventions

DRUG: Febuxostat

Sponsor

SK Chemicals Co., Ltd.